NBY
AMEXNovaBay Pharmaceuticals Inc.
Price$1.95-22.30 (-91.96%)
2025-12-292026-04-02
News · 26 weeks23-100%
2025-12-072026-05-31
Mix1190d
- SEC Filings5(45%)
- Insider4(36%)
- Other1(9%)
- Leadership1(9%)
Latest news
25 items- PRAterian, Inc. Announces Definitive Agreement for the Sale of its Marquee Brand Portfolio for $18 Million Subject to AdjustmentsSUMMIT, N.J., April 28, 2026 (GLOBE NEWSWIRE) -- Aterian, Inc. (NASDAQ:ATER) ("Aterian" or the "Company"), a consumer products company, today announced separate transactions related to its previously announced Strategic Alternative Process. Sale of E-Commerce Brand Portfolio (the "Asset Sale") The Company has signed a definitive agreement with Trademark Global, LLC ("Trademark") for the sale of assets associated with its marquee brands: Mueller Living, PurSteam, hOmeLabs, Squatty Potty, Healing Solutions, and Photo Paper Direct. Under the terms of the purchase agreement for the Asset Sale, Trademark will acquire the worldwide business of sourcing, marketing, and selling products under th
- INSIDERSEC Form 4 filed by Zheng Yenyou4 - Stablecoin Development Corp (0001389545) (Issuer)
- INSIDERSEC Form 4 filed by Law Tommy4 - Stablecoin Development Corp (0001389545) (Issuer)
- SECNovaBay Pharmaceuticals Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Stablecoin Development Corp (0001389545) (Filer)
- INSIDERSEC Form 4 filed by Kazley Michael John4 - Stablecoin Development Corp (0001389545) (Issuer)
- INSIDERSEC Form 4 filed by Sit Swan4 - Stablecoin Development Corp (0001389545) (Issuer)
- SECNovaBay Pharmaceuticals Inc. filed SEC Form 8-K: Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits8-K - Stablecoin Development Corp (0001389545) (Filer)
- SECNovaBay Pharmaceuticals Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits8-K - NovaBay Pharmaceuticals, Inc. (0001389545) (Filer)
- PRNovaBay Pharmaceuticals Announces Name Change to Stablecoin Development Corporation, Reports Initial Staking Rewards, and Provides SKY Token Holdings UpdateFollowing $134 million investment from R01 Fund LP, Framework Ventures, Tether Investments, S.A. de C.V., and Sky Frontier Foundation, Stablecoin Development Corporation has acquired 2.06 billion SKY tokens Key Highlights: Corporate name change from NovaBay Pharmaceuticals, Inc. to Stablecoin Development Corporation; ticker symbol change from NBY to SDEV on the NYSE American, expected to be effective on Friday, April 3, 2026Approximately 2.06 billion SKY tokens held as of March 16, 2026, representing approximately 8.78% of the total supply of SKYApproximately 26.6 million SKY tokens earned in cumulative staking rewards since commencing on-chain staking activitiesApproximately 1.09 billion
- SECSEC Form 10-K filed by NovaBay Pharmaceuticals Inc.10-K - NovaBay Pharmaceuticals, Inc. (0001389545) (Filer)
- SECNovaBay Pharmaceuticals Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits8-K - NovaBay Pharmaceuticals, Inc. (0001389545) (Filer)
- SECSEC Form DEFA14A filed by NovaBay Pharmaceuticals Inc.DEFA14A - NovaBay Pharmaceuticals, Inc. (0001389545) (Filer)
- SECNovaBay Pharmaceuticals Inc. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits8-K - NovaBay Pharmaceuticals, Inc. (0001389545) (Filer)
- SECNovaBay Pharmaceuticals Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - NovaBay Pharmaceuticals, Inc. (0001389545) (Filer)
- SECSEC Form DEF 14A filed by NovaBay Pharmaceuticals Inc.DEF 14A - NovaBay Pharmaceuticals, Inc. (0001389545) (Filer)
- SECNovaBay Pharmaceuticals Inc. filed SEC Form 8-K: Changes in Registrant's Certifying Accountant, Other Events8-K - NovaBay Pharmaceuticals, Inc. (0001389545) (Filer)
- SECSEC Form PRE 14A filed by NovaBay Pharmaceuticals Inc.PRE 14A - NovaBay Pharmaceuticals, Inc. (0001389545) (Filer)
- INSIDERLarge owner Lazar David E. was granted 6,388,000 shares (SEC Form 4)4 - NovaBay Pharmaceuticals, Inc. (0001389545) (Issuer)
- SECNovaBay Pharmaceuticals Inc. filed SEC Form 8-K: Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits8-K - NovaBay Pharmaceuticals, Inc. (0001389545) (Filer)
- SECSEC Form D filed by NovaBay Pharmaceuticals Inc.D - NovaBay Pharmaceuticals, Inc. (0001389545) (Filer)
- SECNovaBay Pharmaceuticals Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits8-K - NovaBay Pharmaceuticals, Inc. (0001389545) (Filer)
- SECSEC Form 424B5 filed by NovaBay Pharmaceuticals Inc.424B5 - NovaBay Pharmaceuticals, Inc. (0001389545) (Filer)
- SECNovaBay Pharmaceuticals Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and Exhibits8-K - NovaBay Pharmaceuticals, Inc. (0001389545) (Filer)
- SECSEC Form EFFECT filed by NovaBay Pharmaceuticals Inc.EFFECT - NovaBay Pharmaceuticals, Inc. (0001389545) (Filer)
- SECSEC Form S-8 filed by NovaBay Pharmaceuticals Inc.S-8 - NovaBay Pharmaceuticals, Inc. (0001389545) (Filer)
NBY FAQ
6 questionsWhat does NovaBay Pharmaceuticals Inc. do?
NovaBay Pharmaceuticals, Inc., a medical device company, develops products for the eye care markets in the United States and internationally. The company offers Avenova, a solution for cleansing and removing foreign materials, including microorganisms and debris from skin around the eye, including the eyelid; CelleRx Clinical Reset, a gentle and soothing facial spray; and NeutroPhase and PhaseOne for the wound care market. It also offers KN95 Masks. The company sells its products through distribution partners, as well as offers Avenova and CelleRx Clinical Reset through online sales channels...Where does NBY stock trade?
NovaBay Pharmaceuticals Inc. (NBY) is listed on AMEX.What sector and industry is NBY in?
NovaBay Pharmaceuticals Inc. operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.When did NovaBay Pharmaceuticals Inc. go public?
NovaBay Pharmaceuticals Inc. (NBY) completed its IPO in 2007.What companies are similar to NBY?
Notable peers in the same industry include LLY (Eli Lilly and Company), AZN (AstraZeneca PLC), JNJ (Johnson & Johnson), ABBV (AbbVie Inc.), MRK (Merck & Company Inc.). Compare NBY side-by-side with any of them on Quantisnow.How can I track NBY on Quantisnow?
Quantisnow aggregates NovaBay Pharmaceuticals Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow NBY to receive live email and push alerts on every new disclosure.